Modular Medical, Inc. received a 180-day extension from Nasdaq to meet the minimum bid price requirement under Nasdaq Listing Rule.
The Company has until June 29, 2026, to achieve a closing bid price of $1.00 per share or more for 10 consecutive business days.
If compliance is not regained within the extended period, Nasdaq may initiate delisting procedures.
Extension Granted
Nasdaq granted Modular Medical, Inc. a 180-day extension to meet the minimum bid price requirement.
Compliance Deadline
The Company must achieve a closing bid price of $1.00 per share or more for 10 consecutive business days by June 29, 2026.
Delisting Risk
Failure to regain compliance with the Bid Price Rule may lead to potential delisting of Modular Medical's common stock.
- The extension gives Modular Medical more time to address its bid price and potentially avoid delisting from Nasdaq.
- The Company must closely monitor its stock price and consider strategic options to ensure compliance with Nasdaq's requirements.
Modular Medical faces a critical deadline to meet Nasdaq's bid price requirement by June 29, 2026, to avoid potential delisting. The Company's continued monitoring and evaluation of compliance options are crucial for its listing status on Nasdaq.